Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on April 10, 2025
U.S. FDA clears first stapler designed for single-port robotic surgery
GlobeNewswire
·
April 10, 2025
SUNNYVALE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food …
Healthcare Integrated Technologies Inc. Welcomes Anand Ijju as its New Chief Technology Officer
GlobeNewswire
·
April 10, 2025
Knoxville, TN, April 10, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces the appointment of Anand Ijju as its new Chief Technology Officer. …
Lipozem Reviews (Customer Reports): I TRIED IT, Tracked It, and Exposed the Good, Bad & Shocking Truth!
GlobeNewswire
·
April 10, 2025
LAKELAND, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- Lipozem was not even on my radar when I first set out to tackle the stubborn weight that had clung to me for years. I’d dabbled in countless diets—strict low-carb regimens, juice cleanses, punishing …
Nature Communications Publishes Pivotal Data From Albatroz Therapeutics Demonstrating That Inhibiting Calnexin Alleviates Arthritis Symptoms and May Reverse Disease Progression
GlobeNewswire
·
April 10, 2025
Study uncovers insights about the progression of arthritis, the leading cause of disability which affects 1 in 5 adults and more than half of seniors age 75+ Publication demonstrates a novel therapeutic approach targeting Calnexin that may prevent …
Nextech and Ocuco Announce Strategic Partnership to Revolutionize Optical Solutions
GlobeNewswire
·
April 10, 2025
Tampa, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- Nextech, a leading technology provider for specialty medical and wellness practices and Ocuco, a global leader in optical software solutions, are excited to announce a strategic partnership to deliver an …
Eleos Expands Executive Leadership Bench Following Series C Fundraise
GlobeNewswire
·
April 10, 2025
BOSTON and TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Eleos, the leader in AI for behavioral health, today announced the appointment of a deep bench of industry-leading executive talent to support the company through its next phase of growth. …
Elixir Medical Announces Launch of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Europe
GlobeNewswire
·
April 10, 2025
Novel IVL technology designed to deliver calcium fragmentation for treatment of moderate to severely calcified coronary artery lesions without requiring an energy source. IVL technology expands company’s innovative product portfolio. MILPITAS, Calif., …
Over 53 Million Myeloma Milestones Shared During 2025 Myeloma Action Month
GlobeNewswire
·
April 10, 2025
STUDIO CITY, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- At the conclusion of this year’s Myeloma Action Month, the International Myeloma Foundation (IMF) was truly grateful and overwhelmed by everyone’s support in making the annual campaign a global …
Senti Bio Bolsters Scientific Advisory Board with Appointment of James B. Trager, Ph.D.
GlobeNewswire
·
April 10, 2025
Industry leader in the development and application of cellular therapies, including CAR NK products, for cancer Led development of multiple clinical candidates from conception through IND and early clinical development Vast experience in technology …
Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21
GlobeNewswire
·
April 10, 2025
WASHINGTON, April 10, 2025 (GLOBE NEWSWIRE) -- Geoff Dow, infectious disease product development expert and chief executive officer of 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), will participate in a scientific …
Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program
GlobeNewswire
·
April 10, 2025
NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 10, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit" or the “Company”) today announced that its Board of Directors has authorized a share repurchase program under which the …
Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel
GlobeNewswire
·
April 10, 2025
Latest granted patents reinforce Pluri’s position as a leader in Mucosal-Associated Invariant T (“MAIT”) cell-based cell therapies for solid cancers Pluri’s MAIT platform enables commercial scale production of powerful immune cells as a potential first-in- …
US Ultrasound Market worth US$3.82 billion by 2030 with 7.6% CAGR | MarketsandMarkets™.
GlobeNewswire
·
April 10, 2025
Delray Beach, FL, April 10, 2025 (GLOBE NEWSWIRE) -- The US Ultrasound Market is projected to reach US$3.82 billion by 2030 from US$2.46 billion in 2024, at a CAGR of 7.6%. The US ultrasound market is growing due to AI-integrated ultrasound imaging …
TYG Training Launches First Canadian Location in Whitby, Bringing Community-Driven Fitness to Durham Region
GlobeNewswire
·
April 10, 2025
WHITBY, Ontario, April 10, 2025 (GLOBE NEWSWIRE) -- TYG Training (TYG) has officially opened its first Canadian location in Whitby at 910 Dundas St W, Unit 104 — a boutique strength and conditioning club designed for all fitness levels and age groups (16 …
Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency
GlobeNewswire
·
April 10, 2025
- Data from the largest retrospective analysis of ENPP1 Deficiency provides insights into the evolution of the disease’s serious cardiovascular and musculoskeletal complications - - Findings highlight the urgent need for early and improved diagnosis, care …
Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder
GlobeNewswire
·
April 10, 2025
Vancouver, Canada, April 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
VitalHub Announces Recommended Cash Acquisition of Induction Healthcare Group PLC
GlobeNewswire
·
April 10, 2025
TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: VHIBF) is pleased to announce that it has agreed the terms and conditions of a recommended cash acquisition to acquire all of the issued and to be …
Evaxion to present at World Vaccine Congress
GlobeNewswire
·
April 10, 2025
Congress will take place April 21-24, 2025, in Washington, D.C. COPENHAGEN, Denmark, April 10, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will give two …
Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor
GlobeNewswire
·
April 10, 2025
SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the appointment of Guy …
BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3
GlobeNewswire
·
April 10, 2025
BriaPro is developing novel antibodies to B7-H3, a key cancer antigen and immune checkpoint Highly expressed on the cell surfaces of both tumor and immune cells, B7-H3 is a promising anti-cancer target for drugs both effecting cancer cells and blocking …